Radiologic Approach to Soft Tissue Sarcomas
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Bone and Soft Tissue Oncology".
Deadline for manuscript submissions: closed (20 December 2022) | Viewed by 2127
Special Issue Editors
Interests: tumour diagnostics; sonography; interventional radiology; peripheral nerves
Special Issue Information
Dear Colleagues,
Soft tissue masses are frequent, as most of them are benign tumours or pseudotumours, and malignant forms are rare. In adults, approximately 1% of malignent neoplasms are soft tissue masses, and approximately 15% in children.. The ratio of benign to malignant soft tissue masses is approximately 100:1.
However, the field of soft tissue sarcomas is challenging, as these rare neoplasms must be diagnosed when small and should be addressed quickly and correctly to achieve the best outcome: classification and grading, as well as staging, are often demanding, and various diagnostic modalities are needed for a straightforward diagnosis. In this context, a multi-faceted approach is usually employed, including radiography, which admittedly plays an subordinate role, magnetic resonance imaging (MRI), and ultrasound (US).
MRI has become the factual main player: impressive images highlight tumours in high contrast and help classify sarcomas according to their size, configuration, and position. For the diagnosis and first assessments of soft tissue sarcomas, sonography has become an indispensable teammate: up-to-date technology and high-frequency probes provide unrivaled, real-time resolution of MSK structures, providing submillimeter-texture depictions that are advantageous for further triage. Additionally, sonography may depict “pathologic” inner vascularity using new Duplex modes or contrast enhancement. An often needed, precise biopsy of a MSK-mass is also within the range of this almost ubiquitous and competitive modality.
So, what is an optimal multimodal approach for diagnosing sarcomas? What is the best modality, or is there even any as standard? How should we assess MSK masses, and which features count?
This Special Issue will provide an overview of the aforementioned topics in the hope that this will help medical practitioners manage patients with potential soft tissue sarcoma in an up-to-date manner.
Dr. Alexander Loizides
Dr. Hannes Gruber
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- musculoskeletal masses
- soft tissue sarcomas
- magnetic resonance imaging
- sonography
- contrast-enhanced ultrasound
- diagnostic features
